1,739
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Perceptions and experiences of control among people living with motor neurone disease: a systematic review and thematic synthesis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 2554-2566 | Received 13 Aug 2021, Accepted 17 Jul 2022, Published online: 01 Aug 2022

References

  • Talbot K. Motor neurone disease. Postgrad Med J. 2002;78(923):513–519.
  • Gordon PH, Cheng B, Salachas F, et al. Progression in ALS is not linear but is curvilinear. J Neurol. 2010;257(10):1713–1717.
  • Holkham L, Soundy A. The experience of informal caregivers of patients with motor neurone disease: a thematic synthesis. Palliat Support Care. 2018;16(4):487–496.
  • Schepelmann K, Winter Y, Spottke AE, et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010;257(1):15–23.
  • Soundy A, Condon N. Patients experiences of maintaining mental well-being and hope within motor neuron disease: a thematic synthesis. Front Psychol. 2015;6:606.
  • Aoun SM, Bentley B, Funk L, et al. A 10-year literature review of family caregiving for motor neurone disease: moving from caregiver burden studies to palliative care interventions. Palliat Med. 2013;27(5):437–446.
  • Radunovic A, Annane D, Rafiq MK, et al. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017;10(10):CD004427.
  • Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218–1226.
  • Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942–955.
  • Aoun SM, O'Brien MR, Breen LJ, et al. The shock of diagnosis’: qualitative accounts from people with motor neurone disease reflecting the need for more person-centred care. J Neurol Sci. 2018;387:80–84.
  • McCabe MP, O'Connor EJ. Why are some people with neurological illness more resilient than others? Psychol Health Med. 2012;17(1):17–34.
  • Eccles FJR, Simpson J. A review of the demographic, clinical and psychosocial correlates of perceived control in three chronic motor illnesses. Disabil Rehabil. 2011;33(13–14):1065–1088.
  • Eccles FJR, Murray C, Simpson J. Perceptions of cause and control in people with Parkinson's disease. Disabil Rehabil. 2011;33(15–16):1409–1420.
  • Bishop M, Frain MP, Tschopp MK. Self-management, perceived control, and subjective quality of life in multiple sclerosis:an exploratory study. Rehabil Couns Bull. 2008;52(1):45–56.
  • Pagnini F, Bercovitz K, Langer E. Perceived control and mindfulness: implications for clinical practice. J Psychother Integr. 2016;26(2):91–102.
  • Neipp López MC, López-Roig S, Pastor MÁ. Control beliefs in cancer: a literature review. Anuario de Psicología. 2007;38(3):333–355.
  • Ferrie JWP, Watson N. Living with MND: an evaluation of care pathways available to adults with and the families or carers of adults with motor neurone disease in Scotland. Glasgow: University of Glasgow; 2013.
  • Sakellariou D, Boniface G, Brown P. Experiences of living with motor neurone disease: a review of qualitative research. Disabil Rehabil. 2013;35(21):1765–1773.
  • Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychol Med. 1994;24(3):625–632.
  • Soofi AY, Bello-Haas V, Kho ME, et al. The impact of rehabilitative interventions on quality of life: a qualitative evidence synthesis of personal experiences of individuals with amyotrophic lateral sclerosis. Qual Life Res. 2018;27(4):845–856.
  • Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):45.
  • Tong A, Flemming K, McInnes E, et al. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12(1):181.
  • Bolmsjo I, Hermeren G. Interviews with patients, family, and caregivers in amyotrophic lateral sclerosis: comparing needs. J Palliat Care. 2001;17(4):236–240.
  • Lule D, Ehlich B, Lang D, et al. Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol. 2013;260(11):2836–2843.
  • Cooke A, Smith D, Booth A. Beyond PICO: the SPIDER tool for qualitative evidence synthesis. Qual Health Res. 2012;22(10):1435–1443.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  • Joanna Briggs I. The Joanna briggs institute critical appraisal tools for use in JBI systematic reviews checklist for qualitative research. Adelade: Joanna Briggs Institute; 2017.
  • Ando H, Chakrabarti B, Angus RM, et al. Experience of long-term use of non-invasive ventilation in motor neuron disease: an interpretative phenomenological analysis. BMJ Support Palliat Care. 2014;4(1):50–56.
  • Ando H, Williams C, Angus RM, et al. Why don't they accept non-invasive ventilation?: Insight into the interpersonal perspectives of patients with motor neurone disease. Br J Health Psychol. 2015;20(2):341–359.
  • Ando H, Cousins R, Young CA. Flexibility to manage and enhance quality of life among people with motor neurone disease. Disabil Rehabil. 2022;44(12):2752.
  • Cave R, Bloch S. Voice banking for people living with motor neurone disease: views and expectations. Int J Lang Commun Disord. 2021;56(1):116–129.
  • Cipolletta S, Gammino GR, Palmieri A. Illness trajectories in patients with amyotrophic lateral sclerosis: how illness progression is related to life narratives and interpersonal relationships. J Clin Nurs. 2017;26(23-24):5033–5043.
  • Foley G, Timonen V, Hardiman O. Exerting control and adapting to loss in amyotrophic lateral sclerosis. Soc Sci Med. 2014;101:113–119.
  • Foley G, Timonen V, Hardiman O. Understanding psycho-social processes underpinning engagement with services in motor neurone disease: a qualitative study. Palliat Med. 2014;28(4):318–325.
  • Greenaway LP, Martin NH, Lawrence V, et al. Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients' perspectives. J Neurol. 2015;262(4):1002–1013.
  • Gysels MH, Higginson IJ. The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND. BMC Palliat Care. 2011;10(pagination):15.
  • Harris DA. Lived-through past, experienced present, anticipated future: understanding "existential loss" in the context of life-limiting illness. Palliat Support Care. 2015;13(6):1579–1594.
  • Harris DA, Jack K, Wibberley C. The meaning of living with uncertainty for people with motor neurone disease. J Clin Nurs. 2018;27(9–10):2062–2071.
  • Hocking C, Brott T, Paddy A. Caring for people with motor neurone disease. J Aust Rehabil Nurses' Assoc. 2006;9(3):24–28.
  • Hogden AV, Greenfield D, Nugus P, et al. What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives. Patient Prefer Adherence. 2012;6:829–838.
  • Mistry K, Simpson J. Exploring the transitional process from receiving a diagnosis to living with motor neurone disease. Psychol Health. 2013;28(8):939–953.
  • Ozanne AO, Graneheim UH, Strang S. Finding meaning despite anxiety over life and death in amyotrophic lateral sclerosis patients. J Clin Nurs. 2013;22(15–16):2141–2149.
  • Pavey A, Warren N, Allen-Collinson J. It gives me my freedom': technology and responding to bodily limitations in motor neuron disease. Med Anthropol. 2015;34(5):442–455.
  • Pinto C, Geraghty AWA, Yardley L, et al. Emotional distress and well-being among people with motor neurone disease (MND) and their family caregivers: a qualitative interview study. BMJ Open. 2021;11(8):e044724.
  • Weeks KR, Gould RL, McDermott C, et al. Needs and preferences for psychological interventions of people with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7–8):521–531.
  • Yuan MM, Peng X, Zeng TY, et al. The illness experience for people with amyotrophic lateral sclerosis: a qualitative study. J Clin Nurs. 2021;30(9–10):1455–1463.
  • Skaff M. Sense of control and health. In Aldwin CM, Park CL, Spiro A, editors. Handbook of health psychology and aging. New York: Guilford Publications; 2007.
  • O'Brien MR, Whitehead B, Jack BA, et al. From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): experiences of people with ALS/MND and family carers – a qualitative study. Amyotroph Lateral Scler. 2011;12(2):97–104.
  • Pavey A, Allen-Collinson J, Pavey T. The lived experience of diagnosis delivery in motor neurone disease: a sociological-phenomenological study. Sociol Res Online. 2013;18(2):36.
  • Andrews EE, et al. Disability models. In: Budd MA, Hough S, Wegener STeditors. Practical psychology in medical rehabilitation. Cham: Springer International Publishing; 2017. p. 77–83.
  • Young C, Ando H, Cousins R, editors. What is unique about quality of life in motor neurone disease?: A qualitative query. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Conference: 25th International Symposium on ALS/MND; 2014; Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Conference: 25th International Symposium on ALS/MND. Brussels Belgium. Conference Publication: (var.pagings). 15 (SUPPL. 1) (pp 117); Informa Healthcare; 2014.
  • Bolmsjo I. Existential issues in palliative care: interviews of patients with amyotrophic lateral sclerosis. J Palliat Med. 2001;4(4):499–505.
  • Lerum SV, Solbraekke KN, Holmoy T, et al. Unstable terminality: negotiating the meaning of chronicity and terminality in motor neurone disease. Sociol Health Illn. 2015;37(1):81–96.
  • Murray SA, Kendall M, Mitchell G, et al. Palliative care from diagnosis to death. BMJ. 2017;356:j878.
  • Oliver DJ. Palliative care in motor neurone disease: where are we now? Palliative Care. 2019;12(1):1–14.
  • Scotland HI. General standards for neurological care and support. Scotland: NHS Scotland; 2019.
  • National Institute for Health and Care Excellence. Motor neurone disease: assessment and management (NICE guideline 42). United Kingdom: National Institute for Health and Care Excellence; 2016.
  • Clarke G, Fistein E, Holland A, et al. Planning for an uncertain future in progressive neurological disease: a qualitative study of patient and family decision-making with a focus on eating and drinking. BMC Neurol. 2018;18(1):115.
  • Foley G, Hynes G. Decision-making among patients and their family in ALS care: a review. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(3–4):173–193.
  • King SJ, Duke MM, O'Connor BA. Living with amyotrophic lateral sclerosis/motor neurone disease (ALS/MND): decision-making about ‘ongoing change and adaptation. J Clin Nurs. 2009;18(5):745–754.
  • Brown JB. User, carer and professional experiences of care in motor neurone disease. Primary Health Care Research & Development. 2003;4(3):207–217.
  • Simmons Z, Bremer BA, Robbins RA, et al. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55(3):388–392.
  • Simmons Z. Patient-Perceived outcomes and quality of life in ALS. Neurotherapeutics. 2015;12(2):394–402.
  • Ganann R, Ciliska D, Thomas H. Expediting systematic reviews: methods and implications of rapid reviews. Implementation Sci. 2010;5(1):1–10.
  • Whitlock EP, Lin JS, Chou R, et al. Using existing systematic reviews in complex systematic reviews. Ann Intern Med. 2008;148(10):776–782.
  • Khangura S, Konnyu K, Cushman R, et al. Evidence summaries: the evolution of a rapid review approach. Syst. 2012;1(1):1–9.
  • Ames H, Glenton C, Lewin S. Purposive sampling in a qualitative evidence synthesis: a worked example from a synthesis on parental perceptions of vaccination communication. BMC Med Res Methodol. 2019;19(1):1–9.
  • Benoot C, Hannes K, Bilsen J. The use of purposeful sampling in a qualitative evidence synthesis: a worked example on sexual adjustment to a cancer trajectory. BMC Med Res Methodol. 2016;16(1):1–12.